Synthesis, structure determination, and biological evaluation of phenylsulfonyl hydrazide derivatives as potential anti-inflammatory agents. 2016

Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
Research Institute for Basic Sciences and Department of Chemistry, College of Sciences, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.

In our previous research, a novel series of phenylsulfonyl hydrazide derivatives were found to reduce LPS-induced PGE2 levels in RAW 264.7 macrophage cells via an inhibition of mPGES-1 enzyme. Recently, it was found that a regioisomeric mixture of phenylsulfonyl hydrazide was formed depending on the reaction conditions, which favor either of two regioisomers. One regioisomer corresponds to a kinetic product (7a-7c) and the other regioisomer corresponds to a thermodynamic product (8a-8c). Among them, the structure of kinetic product 7b was confirmed by measuring single X-ray crystallography. In vitro PGE2 assay studies showed that the kinetic product (7a and 7b; IC50=0.69 and 0.55μM against PGE2) is generally more potent than the thermodynamic product (8a and 8b; IC50=>10 and 0.79μM against PGE2). A molecular docking study also exhibited that the kinetic product (7a) has a higher MolDock Score (-147.4) than that of 8a (-142.4), which is consistent with the PGE2 assay results. A new potent phenylsulfonyl hydrazide (7d; IC50=0.06μM against PGE2) without affecting COX-1 and COX-2 enzyme activities was identified based on these overall results.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics

Related Publications

Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
February 2018, European journal of medicinal chemistry,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
January 2017, Iranian journal of pharmaceutical research : IJPR,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
June 2013, European journal of medicinal chemistry,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
April 2021, RSC medicinal chemistry,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
January 2009, Bioorganic & medicinal chemistry letters,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
January 2017, Current pharmaceutical design,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
September 2014, Fitoterapia,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
March 2004, Bioorganic & medicinal chemistry,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
September 2009, Bioorganic & medicinal chemistry letters,
Eun Beul Park, and Kwang Jong Kim, and Hui Rak Jeong, and Jae Kyun Lee, and Hyoung Ja Kim, and Hwi Ho Lee, and Ji Woong Lim, and Ji-Sun Shin, and Andreas Koeberle, and Oliver Werz, and Kyung-Tae Lee, and Jae Yeol Lee
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!